Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration,Eleni Sofianopoulou,Stephen K Kaptoge,Shoaib Afzal,Tao Jiang,Dipender Gill,Thomas E Gundersen,Thomas R Bolton,Elias Allara,Matthew G Arnold,Amy M Mason,Ryan Chung,Lisa A M Pennells,Fanchao Shi,Luanluan Sun,Peter Willeit,Nita G Forouhi,Claudia Langenberg,Stephen J Sharp,Salvatore Panico,Gunnar Engström,Olle Melander,Tammy Y N Tong,Aurora Perez-Cornago,Margareta Norberg,Ingegerd Johansson,Verena Katzke,Bernard Srour,María José Sánchez,Daniel Redondo-Sánchez,Anja Olsen,Christina C Dahm,Kim Overvad,Magritt Brustad,Guri Skeie,Conchi Moreno-Iribas,N Charlotte Onland-Moret,Yvonne T van der Schouw,Konstantinos K Tsilidis,Alicia K Heath,Claudia Agnoli,Vittorio Krogh,Ian H de Boer,Camilla Jannie Kobylecki,Yunus Çolak,Armin Zittermann,Johan Sundström,Paul Welsh,Elisabete Weiderpass,Elom K Aglago,Pietro Ferrari,Robert Clarke,Marie-Christine Boutron,Gianluca Severi,Conor MacDonald,Rui Providencia,Giovanna Masala,Raul Zamora Ros,Jolanda Boer,Wm Monique Verschuren,Peggy Cawthon,Louise L Schierbeck,Cyrus Cooper,Matthias B Schulze,Manuela M Bergmann,Anke Hannemann,Stefan Kiechl,Hermann Brenner,Natasja M van Schoor,Juan R Albertorio,Carlotta Sacerdote,Allan Linneberg,Line L Kårhus,José María Huerta,Liher Imaz,Christel Joergensen,Yoav Ben-Shlomo,Annamari Lundqvist,John Gallacher,Naveed Sattar,Angela M Wood,Nicholas J Wareham,Børge G Nordestgaard,Emanuele Di Angelantonio,John Danesh,Adam S Butterworth,Stephen Burgess

Abstract:Background: Randomised trials of vitamin D supplementation for cardiovascular disease and all-cause mortality have generally reported null findings. However, generalisability of results to individuals with low vitamin D status is unclear. We aimed to characterise dose-response relationships between 25-hydroxyvitamin D (25[OH]D) concentrations and risk of coronary heart disease, stroke, and all-cause mortality in observational and Mendelian randomisation frameworks. Methods: Observational analyses were undertaken using data from 33 prospective studies comprising 500 962 individuals with no known history of coronary heart disease or stroke at baseline. Mendelian randomisation analyses were performed in four population-based cohort studies (UK Biobank, EPIC-CVD, and two Copenhagen population-based studies) comprising 386 406 middle-aged individuals of European ancestries, including 33 546 people who developed coronary heart disease, 18 166 people who had a stroke, and 27 885 people who died. Primary outcomes were coronary heart disease, defined as fatal ischaemic heart disease (International Classification of Diseases 10th revision code I20-I25) or non-fatal myocardial infarction (I21-I23); stroke, defined as any cerebrovascular disease (I60-I69); and all-cause mortality. Findings: Observational analyses suggested inverse associations between incident coronary heart disease, stroke, and all-cause mortality outcomes with 25(OH)D concentration at low 25(OH)D concentrations. In population-wide genetic analyses, there were no associations of genetically-predicted 25(OH)D with coronary heart disease, stroke, or all-cause mortality. However, for the participants with vitamin D deficiency (25[OH]D concentration <25 nmol/L), genetic analyses provided strong evidence for an inverse association with all-cause mortality (odds ratio [OR] per 10 nmol/L increase in genetically-predicted 25[OH]D concentration 0·69 [95% CI 0·59-0·80]; p<0·0001) and non-significant inverse associations for stroke (0·85 [0·70-1·02], p=0·09) and coronary heart disease (0·89 [0·76-1·04]; p=0·14). A finer stratification of participants found inverse associations between genetically-predicted 25(OH)D concentrations and all-cause mortality up to around 40 nmol/L. Interpretation: Stratified Mendelian randomisation analyses suggest a causal relationship between 25(OH)D concentrations and mortality for individuals with low vitamin D status. Our findings have implications for the design of vitamin D supplementation trials, and potential disease prevention strategies. Funding: British Heart Foundation, Medical Research Council, National Institute for Health Research, Health Data Research UK, Cancer Research UK, and International Agency for Research on Cancer.

Vitamin D Status and Epigenetic-Based Mortality Risk Score: Strong Independent and Joint Prediction of All-Cause Mortality in a Population-Based Cohort Study

Comparative Validation of an Epigenetic Mortality Risk Score with Three Aging Biomarkers for Predicting Mortality Risks among Older Adult Males

Oxidative Stress and Epigenetic Mortality Risk Score: Associations with All-Cause Mortality among Elderly People

Leukocyte telomere length and epigenetic-based mortality risk score: associations with all-cause mortality among older adults.

Integrative analysis of clinical and epigenetic biomarkers of mortality

Serum 25-Hydroxyvitamin D Levels as an Aging Marker: Strong Associations With Age and All-Cause Mortality Independent From Telomere Length, Epigenetic Age Acceleration, and 8-Isoprostane Levels

Blood DNA Methylation Sites Predict Death Risk in a Longitudinal Study of 12, 300 Individuals

Combined effects of vitamin D deficiency and systemic inflammation on all-cause mortality and cause-specific mortality in older adults

Association of Serum 25-Hydroxyvitamin D with the Incidence of 16 Cancers, Cancer Mortality, and All-Cause Mortality among Individuals with Metabolic Syndrome: a Prospective Cohort Study

Combined Associations of Vitamin D and Cognitive Function with All-Cause Mortality among Older Adults in Chinese Longevity Areas: A Prospective Cohort Study.

Characterization of methylation patterns associated with lifestyle factors and vitamin D supplementation in a healthy elderly cohort from Southwest Sweden

Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study

A Putative Causality of Vitamin D in Common Diseases: A Mendelian Randomization Study.

Epigenetic prediction of complex traits and death

DNA methylation age of blood predicts all-cause mortality in later life

DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination

Associations of the Serum Vitamin D with Mortality in Postmenopausal Women

Association between DNA methylation predicted growth differentiation factor 15 and mortality: results from NHANES 1999–2002

Vitamin D Status and Mortality Risk among Patients on Dialysis: a Systematic Review and Meta-Analysis of Observational Studies.

Multiple vitamin co-exposure and mortality risk: A prospective study

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses